Meghan et al. reported that IGF-1R acts as a stimulator to activate its downstream Src/MAPK/Egr-1 signaling pathway, which regulates secretory clusterin protein (sCLU) pro-survival pathway and plays an important role in radiation resistance in cancer therapy [17]. This evidence concerns the gene IGF1R and cancer.